Literature DB >> 30362867

Influence of Patients' Age in the Utilization of Esophagectomy for Esophageal Adenocarcinoma.

Francisco Schlottmann1,2, Paula D Strassle1,3, Daniela Molena4, Marco G Patti1,5.   

Abstract

BACKGROUND: The indication of surgical resection in esophageal cancer is often conditioned by patient's age. We aimed to assess the trends in utilization of surgical treatment for esophageal adenocarcinoma (EAC) in the United States, stratified by age groups.
METHODS: We performed a retrospective analysis of the National Cancer Institute's Surveillance, Epidemiology, and End Results program registry for the period 2004-2014. Adult patients (aged ≥18 years) diagnosed with EAC were eligible for inclusion. The yearly incidence of esophagectomy, stratified by age groups (18-49, 50-70, and >70 years old), was calculated using Poisson regression. Weighted log-binomial regression was used to compare the proportion of patients undergoing esophagectomy, within each age group. Inverse probability of treatment weights were used to account for potential confounders.
RESULTS: A total of 21,301 patients were included. During the study period, the rate of esophagectomy decreased from 34.1% to 28.2% (P = .40) in patients between 18 and 49 years old, from 38.6% to 33.3% (P = .06) in patients between 50 and 70 years old, and from 21.4% to 16.9% (P = .04) in patients older than 70 years. After accounting for patient and cancer characteristics, patients older than 70 years were 50% less likely to undergo esophagectomy compared with both patients between 18 and 49 years old (risk ratio [RR] 0.51, 95% confidence interval [CI] 0.45-0.57, P < .0001) and patients between 50 and 70 years old (RR 0.53, 95% CI 0.50-0.56, P < .0001).
CONCLUSION: Surgical resection is scarcely used in patients older than 70 years in the United States. Further investigation of surgical outcomes in elderly patients is warranted to determine if surgical treatment is underutilized in a large proportion of EAC patients.

Entities:  

Keywords:  elderly; esophageal adenocarcinoma; esophagectomy

Mesh:

Year:  2018        PMID: 30362867      PMCID: PMC6909734          DOI: 10.1089/lap.2018.0434

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  18 in total

1.  Racial disparities in esophageal cancer treatment and outcomes.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Thomas G McGinn; Juan P Wisnivesky
Journal:  Ann Surg Oncol       Date:  2007-11-07       Impact factor: 5.344

2.  Barriers to Accessing Optimal Esophageal Cancer Care for Socioeconomically Disadvantaged Patients.

Authors:  Christina M Lineback; Colin M Mervak; Sha'shonda L Revels; Micheal T Kemp; Rishindra M Reddy
Journal:  Ann Thorac Surg       Date:  2016-11-05       Impact factor: 4.330

3.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

4.  Esophagectomy for cancer in octogenarians: should we do it?

Authors:  Elizabeth Paulus; Caroline Ripat; Vadim Koshenkov; Angela T Prescott; Kiran Sethi; Heather Stuart; Gregory Tiesi; Alan S Livingstone; Danny Yakoub
Journal:  Langenbecks Arch Surg       Date:  2017-03-16       Impact factor: 3.445

5.  Underuse of esophagectomy as treatment for resectable esophageal cancer.

Authors:  E Carter Paulson; Jin Ra; Katrina Armstrong; Christopher Wirtalla; Francis Spitz; Rachel Rapaport Kelz
Journal:  Arch Surg       Date:  2008-12

6.  Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA.

Authors:  Daniela Molena; Miloslawa Stem; Amanda L Blackford; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2016-08-15       Impact factor: 3.452

7.  Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.

Authors:  Lauren J Taylor; Caprice C Greenberg; Anne O Lidor; Glen E Leverson; James D Maloney; Ryan A Macke
Journal:  Cancer       Date:  2016-09-28       Impact factor: 6.860

8.  Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.

Authors:  Oliver Pech; Andrea May; Hendrik Manner; Angelika Behrens; Jürgen Pohl; Maren Weferling; Urs Hartmann; Nicola Manner; Josephus Huijsmans; Liebwin Gossner; Thomas Rabenstein; Michael Vieth; Manfred Stolte; Christian Ell
Journal:  Gastroenterology       Date:  2013-11-20       Impact factor: 22.682

9.  Racial disparities in esophageal cancer outcomes.

Authors:  Sha'shonda L Revels; Arden M Morris; Rishindra M Reddy; Clifford Akateh; Sandra L Wong
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

10.  Trends in esophageal adenocarcinoma incidence and mortality.

Authors:  Chin Hur; Melecia Miller; Chung Yin Kong; Emily C Dowling; Kevin J Nattinger; Michelle Dunn; Eric J Feuer
Journal:  Cancer       Date:  2012-12-11       Impact factor: 6.860

View more
  1 in total

1.  Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.

Authors:  Jiayue Ye; Sheng Hu; Wenxiong Zhang; Deyuan Zhang; Yang Zhang; Dongliang Yu; Jinhua Peng; Jianjun Xu; Yiping Wei
Journal:  Front Surg       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.